Trial intelligence / Profile preview

Diovan to Maintain Sinus Rhythm in Persistent Atrial Fibrillation

NCT00343499Phase 4Terminated

Sponsor
Intermountain Health
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan in Atrial fibrillation (AFib), sponsored by Intermountain Health. Started Nov 2004; status: terminated.

02

Drugs

valsartan
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00343499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00343499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call